These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1009528)

  • 1. Further experience with isophosphamide.
    Falkson G; Falkson HC
    Cancer Treat Rep; 1976 Jul; 60(7):955-7. PubMed ID: 1009528
    [No Abstract]   [Full Text] [Related]  

  • 2. [1st clinical experiences with isophosphamide. Long-term results of 2 therapeutic approaches].
    Pigatto JC
    Prensa Med Argent; 1971 Oct; 58(32):1618-21. PubMed ID: 4943249
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of a cyclophosphamide therapy in genital and mammary carcinomas].
    Naumann R
    Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with cyclophosphamide treatment over 10 years in a general medicine ward].
    Laursen MW
    Nord Med; 1971 Apr; 85(16):503. PubMed ID: 5103296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of large single doses of cyclophosphane (endoxan)].
    Garin AM
    Vopr Onkol; 1970; 16(11):43-8. PubMed ID: 4929048
    [No Abstract]   [Full Text] [Related]  

  • 6. The anticancer spectrum of ifosfamide.
    Hunter HL; Harrison EF
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):96-100. PubMed ID: 6761868
    [No Abstract]   [Full Text] [Related]  

  • 7. Ifosfamide--pharmacology, safety and therapeutic potential.
    Brade WP; Herdrich K; Varini M
    Cancer Treat Rev; 1985 Mar; 12(1):1-47. PubMed ID: 3896483
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antineoplastic polychemotherapy in thoracic pathology].
    Mannes P; Derriks R; Moens R; Heynen E
    Poumon Coeur; 1968; 24(1):83-91. PubMed ID: 4968018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endoxan in ovarian cancer].
    Campodónico I; Soldati A; Rodríguez A
    Rev Chil Obstet Ginecol; 1974; 39(3):87-9. PubMed ID: 4620179
    [No Abstract]   [Full Text] [Related]  

  • 10. [Two cases of methemoglobinemia caused by anti-cancer drugs (author's transl)].
    Nakao I; Harashima S; Narui T; Nakagawa K
    Rinsho Ketsueki; 1978 Mar; 19(3):246-51. PubMed ID: 702811
    [No Abstract]   [Full Text] [Related]  

  • 11. Re-evaluation of methotrexate as an anticancer drug.
    Sullivan RD; Miller E; Zurek WZ; Oberfield RA; Ojima Y
    Surg Gynecol Obstet; 1967 Oct; 125(4):819-24. PubMed ID: 6041727
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with large doses of Endoxan].
    Araujo E; Estevez R; Sanchez Suarez R; Chacon R; Gonzalez G
    Med Monatsschr; 1967 Aug; 21(8):371-3. PubMed ID: 5597100
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of cyclophosphamide and isophosphamide on Lewis lung carcinoma.
    Corsi A; Calabresi F; Greco C
    Br J Cancer; 1978 Nov; 38(5):631-3. PubMed ID: 728352
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
    Teufel G; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxol improves outlook for lung, breast, and ovarian cancer.
    Oncology (Williston Park); 1992 Aug; 6(8):16. PubMed ID: 1354469
    [No Abstract]   [Full Text] [Related]  

  • 16. Ifosfamide treatment of advanced ovarian cancer.
    Yazigi R; Wild R; Madrid J; Arraztoa J
    Obstet Gynecol; 1984 Feb; 63(2):163-6. PubMed ID: 6694809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of drug resistance in human breast and ovarian cancers.
    Kern DH
    Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticancer treatment and bromelains].
    Gerard G
    Agressologie; 1972; 13(4):261-74. PubMed ID: 4678520
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment with large doses of cyclophosphamide of breast cancer with metastases to solid viscera].
    Chrapowicki A
    Wiad Lek; 1971 Dec; 24(24):2323-6. PubMed ID: 5139720
    [No Abstract]   [Full Text] [Related]  

  • 20. A case-control study of leukaemia as a second primary malignancy following ovarian and breast neoplasms.
    Mehnert WH; Haas JF; Kittelmann B; Staneczek W; Möhner M; Kaldor JM; Day NE
    IARC Sci Publ; 1986; (78):203-21. PubMed ID: 3583391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.